In recent years, India has emerged as a formidable player in the global biotechnology arena. With an ecosystem rich in innovation, strategic government support, and a burgeoning market, India is not just participating but is set to lead on the biotech stage. This article explores the multifaceted dynamics of India’s biotech sector, illustrating how it […]
AI’s Top 15: Biotech’s Drug Discovery Leaders
In 2024, artificial intelligence (AI) is revolutionizing biotechnology, particularly in drug discovery. AI is reshaping the development of new therapies, making personalized medicine increasingly achievable. This article highlights fifteen leading AI-enabled biotech companies driving these healthcare advancements.
Sustainable Advances in Microbial Fermentation: Science Meets Ecology
Microbial fermentation, an age-old biotechnological process, is undergoing a remarkable transformation, catalyzed by advancements in science and an urgent need for sustainable solutions. This process, which utilizes microorganisms to convert organic substrates into valuable products, stands at the confluence of traditional knowledge and modern technological innovations, offering a promising path towards a more sustainable and […]
FDA Approves Earlier Use of Abecma CAR-T Therapy for Myeloma
The FDA has approved Bristol Myers Squibb and 2seventy Bio’s CAR-T therapy, Abecma, for earlier use in treating multiple myeloma, a type of blood cancer. This approval permits the use of Abecma in adults who have already received at least two prior treatments for relapsed or refractory forms of the disease. The FDA’s decision, which […]
Onego Bio’s Leap in Animal-Free Egg Production
Onego Bio Secures $40M Funding: In a major advancement, Onego Bio has successfully concluded a $40 million Series A funding, aimed at scaling its groundbreaking animal-free egg protein, Bioalbumen®. This represents a significant milestone in the Nordics, cumulatively raising Onego’s funds to $56M. Key Recent Highlights: Leadership in Precision Fermentation: With this investment, Onego Bio […]
AI’s Leap in Gene Therapy: Transforming Viral Vector Design
In the cutting-edge realm of biopharmaceuticals and biotechnology, the design of viral vectors emerges as a cornerstone of innovation, holding the key to groundbreaking advancements in gene therapy, vaccines, and genetic research. By exploiting viruses’ natural capability to deliver genetic material to cells, viral vector technology promises to redefine therapeutic approaches. However, the sophistication involved […]
ARCA and Oruka: New Era in Skin Care
In a strategic move aimed at transforming the treatment landscape for chronic skin diseases, ARCA biopharma, Inc. and Oruka Therapeutics have agreed to a merger, focusing on advancing novel biologics for conditions such as plaque psoriasis. Here’s a concise overview of the key points from the merger announcement: This merger represents a focused strategy to […]
“10x Genomics Launches Visium HD: A Leap in Spatial Biology
Yesterday, 10x Genomics, Inc., a pioneer in the realms of single-cell and spatial biology, proudly announced the release of its Visium HD Spatial Gene Expression product. This groundbreaking tool, designed for the detailed exploration of the whole transcriptome from FFPE tissue sections at a single-cell resolution, sets a new benchmark in the field. Yesterday’s Highlights: […]
Crash Course on mRNA Therapeutics and the CDMO Space
Understanding mRNA Therapy: A Primer mRNA (messenger RNA) therapy is a revolutionary approach in biotechnology that utilizes synthetic mRNA to instruct cells to produce therapeutic proteins. This strategy can be applied to a wide array of diseases, including infectious diseases, cancer, and genetic disorders. Unlike traditional therapies that often introduce proteins or small molecules to […]
Epigenetic Revolution: Redefining Medicine’s Frontier
The global epigenetics market is set to soar, projected to reach $6.35 billion by 2032 from $2.14 billion in 2023, according to a recent Precedence Research report. Driving this surge are pioneering ventures like Moonwalk Biosciences, led by CRISPR luminary Feng Zhang, and Novo Nordisk’s partnership with Omega Therapeutics, signaling a seismic shift in the […]
AbbVie’s Landos Biopharma Acquisition Sparks Stock Surge
Yesterday, Landos Biopharma (LABP) experienced a significant surge in its stock price, rising by an impressive 168%. This surge was fueled by AbbVie’s acquisition announcement, wherein AbbVie revealed plans to acquire Landos Biopharma for $137.5 million, with an additional $75 million contingent upon specific milestones. The acquisition deal includes a cash offer of $20.42 per […]
Top 5 Microbiome Mavericks in 2024
In the vast universe of biopharma, a new constellation of stars is rising, promising to redefine our approach to health and disease. These are microbiome companies, and they’re not just changing the game; they’re playing an entirely new one. Finch Therapeutics operates on the cutting edge of microbiome science, focusing on developing novel microbial therapies. […]
2024 CDMO Sector Evolution: Key Trends
In 2024, the CDMO sector is navigating through transformative changes driven by customer needs, agility, digitalization, and environmental sustainability. These trends are shaping the future of pharmaceutical manufacturing with a focus on excellence. 1. Customer-Centric Initiatives:– Operations and designs are finely tuned to the specific requirements of biopharma clients, ensuring services are aligned with customer […]